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ABSTRACT A recombinant vaccinia virus containing a
Drosophila potassium channel (Shaker H4) cDNA was con-
structed by homologous recombination between wild-type vac-
cinia virus DNA and a transfer plasmid. The new virus was
used to infect four types of mammalian cells in culture.
Electrophysiological recording 24-72 hr after infection re-
vealed the expression of voltage-gated transient potassium
channels in all four cell types. The properties of the induced
currents were identical to those previously observed following
injection of the Shaker H4 transcript into oocytes. Vaccinia
promises to be an effective vehicle for the heterologous expres-
sion of transmembrane ion channels in a variety of cell types.
One of the most important benefits realized from the molec-
ular cloning ofcDNAs encoding ion-channel and transmitter-
receptor peptides has been the opportunity to achieve func-
tional expression of the clones in foreign cells (1). Microin-
jected Xenopus oocytes and stably transfected cell lines
constitute the two usual systems for such heterologous
expression at present. Important applications of heterolo-
gous expression include confirmation of a clone's identity,
studies of pharmacological and kinetic diversity among pro-
teins encoded by homologous cloned mRNAs, structure-
function studies that measure changes in function introduced
by manipulations of the amino acid sequence, and the isola-
tion of new cDNA clones.
Both oocytes and stably transfected cell lines present
unique technical advantages for such studies. We have begun
to explore another type of transient expression system with
the hope that it will prove to be a useful complement to the
more widely used methods. We describe here the use of
vaccinia virus (VV) to achieve the transient expression of a
voltage-gated ion channel in cultured cells. Vaccinia pres-
ently constitutes an important tool for heterologous expres-
sion of both soluble and membrane-bound proteins in animal
cells (2-4). Because VV has a broad host range, it can be used
to study cell-specific processing or modulation of a given
gene product (5). Because VV carries its own polymerases
and replicates in the cytoplasm, its transcripts are not likely
to be subjected to fortuitous splicing.
We have constructed a recombinant VV in which the
coding region of a Drosophila transient potassium channel
cDNA, Shaker H4 (6), was placed downstream of the VV
7.5-kDa promoter and inserted into the nonessential VV
thymidine kinase gene. We have infected a variety of cells in
culture with the recombinant virus (VV:H4) and have ob-
served robust expression of ion channels that are very similar
to both the Shaker H4 potassium channel as it is expressed
in oocytes and the channels responsible for transient potas-
sium currents in Drosophila muscle cells (7).
MATERIALS AND METHODS
Viruses and Cells. The WR strain of VV (wild type;
VV:WT) and the recombinant virus (VV:H4) were propa-
gated separately in African green monkey BSC-40 cells and
purified as previously described (8). Thymidine kinase-
negative L cells (Ltk-) and BSC-40 cells were laboratory
stocks (G.T. lab). Rat basophilic leukocytes (RBL-1 cells)
and NIH mouse 3T3 fibroblasts were obtained from the
American Type Culture Collection. Monkey kidney CV-1
cells were obtained from S. Subramani (University of Cali-
fornia, San Diego), and rat adrenal pheochromocytoma PC-
12 cells were obtained from L. Greene (Columbia Universi-
ty). Cells were maintained in temperature- and C02-
controlled incubators under appropriate culture conditions.
Construction of the Recombinant Virus. The Shaker H4
cDNA (2.2 kilobases) was excised from the multiple cloning
site of pBluescript (Stratagene) by partial digestion with
BamHI followed by complete digestion with Cla I. The
BamHI-Cla I fragment (containing one internal BamHI site)
was purified by agarose gel electrophoresis and subcloned
into the vaccinia recombination plasmid pVV3 (8), which had
been digested to completion with BamHI and Cla I. This
placed the initiation codon of the H4 cDNA 17 base pairs
downstream from the end of the 5' VV flanking sequence
containing the vaccinia 7.5-kDa promoter. The resultant
plasmid (pVV3:H4) was amplified in Escherichia coli and
purified by two cycles of cesium chloride centrifugation. The
pVV3:H4 plasmid DNA was mixed with VV:WT genomic
DNA and transfected by calcium phosphate precipitation into
Ltk- cells that had been infected with VV:WT virus 3 hr
earlier. A recombinant virus containing the H4 cDNA in-
serted within the viral thymidine kinase gene was identified
and purified by marker rescue (9, 10).
Viral Infections. Infections for marker rescue and propa-
gation of the virus were carried out in 100-mm tissue culture
dishes as described (8). Infections for electrophysiology
experiments were carried out on nearly confluent sheets of
cells in T-250 culture flasks. Cells were rinsed with phos-
phate-buffered saline containing 1 mM MgCl2 (PBS/Mg2+)
and were infected with either wild-type virus or the recom-
binant VV:H4 at a multiplicity of infection of 1-5 per cell for
20-30 min in PBS/Mg2+ at room temperature. The virus-
containing medium was replaced by Eagle's minimum essen-
tial medium plus 10% fetal bovine serum, and the cells were
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incubated at 370C. One hour after infection, the cells were
dispersed with trypsin, replated into several 35-mm tissue
culture dishes (-104 cells per dish), and allowed to grow at
370C overnight prior to recording.
Electrophysiology. Individual tissue culture dishes contain-
ing infected cells were rinsed three times with bath solution
(110 mM NaCl/2.5 mM KCl/1.0 mM CaC12/2.0 mM MgCl2/
10mM potassium Hepes/10mM glucose/5 mM pyruvate, pH
7.2) and placed on the stage of an inverted microscope
equipped with Hoffman modulation contrast optics. Voltage-
activated currents were measured by whole-cell patch-clamp
recording (Axoclamp-lA; Axon Instruments, Burlingame,
CA). Pipets were pulled in two stages from Kimax borosili-
cate glass tubing (outer diameter, 1.8 mm) and heat-polished
to a final diameter of -1 Am. Pipets were filled with intra-
cellular solution (145 mM potassium glutamate/8mM NaCl/3
mM MgCl2/2 mM ATP/0.3 mM GTP/0.5 mM EGTA/10 mM
sodium Hepes, pH 7.2) and had a final resistance of 3-10 MO.
Stimulation, data acquisition, and analysis were performed
with the aid of a microcomputer using pCLAMP software
(Axon Instruments). Series resistance was compensated 10-
80%. Digital leak subtraction was sometimes used. All ex-
periments were performed at room temperature (19-22°C).
RESULTS
Cultured Cells Infected with VV:H4 Recombinant Virus
Express Transient Outward Currents. Voltage-clamp record-
ings of whole-cell membrane currents were made from four
types of cultured cells 24-72 hr after infection with the
recombinant VV:H4. Fig. 1 compares waveforms of voltage-
clamp currents elicited by depolarizing voltage steps from a
holding potential of -100 mV for one cell of each type.
VV:H4-infected cells displayed a transient outward current
that was active at membrane potentials above -40 mV.
Control cells, either noninfected or infected with VV:WT,
exhibited no such currents (data not shown). The waveforms
of the VV:H4-induced currents were the same in each of the
four cell types, even though each cell type displayed different
intrinsic properties. For example, rat basophilic leukemia
RBL-1 cells (Fig. 1B) had high input resistance (>100 MI)
and there appeared to be no other currents activated in the
voltage range used to elicit the vaccinia-induced currents.
Both control and VV:H4-infected PC-12 cells, however,
exhibited a large (1-2 nA), slowly activating (t1/2 20 ms)
outward current whose range of activatiorn overlapped par-
tially with that of the VV:H4-induced transient outward
current (Fig. 1D). Changing the holding potential to -30 mV
completely inactivated the transient currents, leaving only
the maintained outward current (Fig. 1E). The waveform of
the transient current at each voltage was obtained by sub-
tracting the family of traces recorded when the holding
potential was - 30 mV from those recorded when the holding
potential was -100 mV. The subtraction currents (Fig. 1F)
resembled the transient outward currents recorded from
infected RBL-1 cells. In both CV-1 (Fig. 1A) and NIH 3T3
cells (Fig. 1C), the VV:H4-induced transient outward cur-
rents were the only time- and voltage-dependent currents
observed in the voltage range tested; however, both of these
cell types exhibited large leakage currents (with or without
infection). Removal of currents other than the transient
outward current induced by infection could be accomplished
by a number of methods (see Fig. 1 legend). Clearly, the
RBL-1 cells presented the most favorable background for
studying the kinetics of the VV:H4-induced currents.
The overall efficiency of expression, meaning the fraction
of nominally infected cells expressing transient outward
currents, was =50% for PC-12, RBL-1, and CV-1 cells. The
efficiency was lower (-'10%) in the NIH 3T3 cells. We
presume that this difference arose from a lower rate of
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FIG. 1. Currents elicited by depolarizing voltage steps in cells
infected with VV:H4 virus. (A) CV-1 cell. (B) RBL-1 cell. (C) NIH
3T3 cell. (D-F) PC-12 cell. Each trial comprised a family of 80-ms
steps to voltages from -80 mV to +30 mV in 10-mV increments from
a holding potential (VH) of -100 mV (A, B, and D) or -30 mV (E).
Leak and capacitive currents in A and B were eliminated by digital
subtraction. Traces in C are the result of subtraction of records at VH
= -30 from records at VH = -100 to remove leakage currents
(individual records not shown). Transient outward currents in the
PC-12 cell (F) were isolated from the maintained outward currents
(E) by similar subtraction from traces in D. Current amplitude scale
is indicated within each panel; time scale is the same (10 ms) for each.
Temperature, 19-210C.
infection ofthe 3T3 cells, since the magnitudes ofthe currents
expressed in "positive" 3T3 cells were among the largest of
all the cell types. Furthermore, >80% of cells displaying
morphological characteristics of viral infection, such as a
slightly rounded profile, were found to be positive for expres-
sion of Shaker-like currents. Based on the single-channel
conductance of the Shaker H4 channel expressed in oocytes
(6), and the amplitudes of macroscopic currents we recorded
from cells of known diameter, we estimate the density of
functional channels induced by VV:H4 infection to be in the
range of 1-5 per gm2 of plasma membrane.
Transient Currents in all Four Cell Types Show the Same
Voltage Dependence of Activation and Inactivation. Fig. 2A
shows the normalized peak current amplitudes of the tran-
sient outward currents elicited by a family of depolarizing
voltage steps from a holding potential of -100 mV for one cell
of each type studied. The values superimpose, indicating that
the voltage dependence of activation was the same in each
cell. The threshold for activation (-40 to -30 mV) is the same
as that reported for the Shaker H4 cDNA expressed in
oocytes (6) and is also the same as that reported for one type
of transient potassium current (A current) recorded from
embryonic Drosophila muscle cells in culture (11).
Just as the process of activation of the A-type current is
voltage-dependent, so is the process of inactivation. As
described above, no transient outward current was elicited
when depolarizing voltage steps were delivered from a hold-
ing potential of -30 mV; the channels were completely
r-
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inactivated. As shown in Fig. 2B, the degree of inhibition
produced by a short conditioning prepulse is a steep function
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of its voltage. Recovery from inactivation occurred rapidly
only at hyperpolarized membrane potentials. Fig. 2C shows
the time course of recovery at -100 mV from inactivation
induced by an 80-ms voltage step to +20 mV. Both the
voltage for half-inactivation (-36 mV; Fig. 2B) and the time
constant for recovery from inactivation ( = 38 msec; 90%
recovery in 200 ms; Fig. 2C) agree with the values obtained
by expression of the H4 cDNA in oocytes (6) and with those
reported for Drosophila A-current channels (11, 12).
Kinetics of Activation and Inactivation Are Voltage-
Dependent. It is apparent (e.g., Fig. 1) that the VV:H4-
induced currents peaked sooner and also decayed more
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FIG. 2. Voltage dependence of activation and steady-state inac-
tivation of transient outward currents elicited by infection with
VV:H4. Cell types: o, RBL-1; o, CV-1; v, NIH 3T3; A, PC-12. (A)
Voltage dependence of activation. Voltage steps (80-ms duration) to
levels shown on the abscissa were delivered from a holding potential
of -100 mV; the peak current, measured after leak subtraction, is
plotted on the ordinate. Peak current at each voltage is normalized
relative to the peak current at 0 mV. Data are from one cell of each
type, as indicated in the key above. (B) Steady-state inactivation. A
100-ms prepulse to a value between -80 mV and + 10 mV preceded
each test pulse to +20 mV. The ratio of peak current during the test
pulse relative to that recorded with a prepulse to -100 mV (IlImax) is
plotted as a function of the prepulse voltage. Points are mean values
from more than one cell of each type, except for PC-12, which is from
a single cell. Error bars are SEM, shown where they exceed symbol
size. Continuous line is the best fit of a Boltzman distribution, P(V) =
I/Ima = {1 + exp[(V- Vi/2)/z]}1-, to all the points shown. P(V) is the
fraction of activatable current remaining following a prepulse to
voltage V. The voltage for half-inactivation, V1/2 = -36 mV; the
voltage for an e-fold change, z = 8 mV. (C) Recovery from inactiva-
tion. The voltage was held at -100 mV except for paired steps to +20
mV for 80 ms; the interval between steps was varied between 2 and
295 ms. The ratio of the peak current during the second step to that
during the first step is plotted against the interval between steps. The
time between trials was 2 sec, which allowed for full recovery of the
currents. Data are from single cells. The continuous line is the best fit
of a single exponential to all the data shown; T = 38 ms.
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FIG. 3. Voltage dependence of activation and inactivation phases
of transient outward currents in VV:H4-infected RBL-1 cell. (A)
Current traces (dots) elicited by depolarizing voltage steps to -20, 0,
and +20 mV from a holding potential of -100 mV are superimposed
on separate functions for the rising and falling phases (solid lines),
determined with nonlinear fits. Rising phases are fit by a third-order
exponential, A[1 - exp(-t/T0.t)]3; falling phases are fit by single
exponentials. (B) Voltage dependence of Tact, plotted on a semilog-
arithmic scale. The line is a least-squares fit to the data points and
corresponds to an e-fold change for 22 mV. Data are from a complete
family of voltage steps for the cell of A. (C) Voltage dependence of
inactivation. Time constants, Tinact, from exponential fits to falling
phases of the current traces are plotted against test potential on a
semilogarithmic scale. The rate of inactivation is not a single-
exponent.al function of voltage.
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rapidly with larger depolarizations. Due to the favorable
membrane properties of the RBL-1 cells and the high levels
of expression, we were able to study the waveforms in detail
(Fig. 3). The rising (activation) phases were well fit by a
third-order exponential process (Fig. 3A). One interpretation
of such a time course (13) is that three or more independent
events (such as charge movement within each subunit of a
multimeric channel protein) are required for the channel to
open. The activation time constant, Tact, varied between 1.9
ms at -40 mV and 0.34 ms at +20 mV and depended
exponentially on voltage (e-fold per 22 mV; Fig. 3B). The
decay phase at each voltage was fit by a single exponential
(see Fig. 3A legend). The inactivation time constant, Tinact,
varied from 90 ms at -30 mV to 3.6 ms at +20 mV and did
not display a simple exponential dependence on voltage (Fig.
3C). Tail currents (Fig. 4) reversed near the calculated
equilibrium potential for potassium, implying a high selec-
tivity for potassium ions. The tail currents decayed with a
single exponential time course (: 2 ms) that was not
strongly voltage-dependent.
Induced A-Type Currents Are Blocked by 4-Aminopyridine
and Charybdotoxin. One of the hallmarks of A-current po-
tassium channels is their sensitivity to 4-aminopyridine. Fig.
SA shows the development of and recovery from block by
4-aminopyridine of the VV:H4-induced currents in an RBL-1
cell. Currents induced by VV:H4 infection of the other cell
types were similarly blocked. Currents were also blocked by
10 nM charybdotoxin (Fig. SB), but recovery was incomplete.
Charybdotoxin blocks A currents expressed in oocytes after
injection of Shaker H4 transcript (14), but it does not block
A currents in Drosophila muscle (15, 16).
DISCUSSION
This study demonstrates that VV is an efficient tool for the
heterologous expression of a voltage-gated ion channel in
animal cells. There are several useful systems for heterolo-
gous expression of cloned cDNAs, including injection of in
vitro transcripts into Xenopus oocytes and stable transfection
of cDNA constructs into cell lines. Like oocytes, vaccinia
has the disadvantage of being a transient expression system,
but the period of viability of the infected cells is more than
sufficient for electrophysiological investigations. For certain
experiments requiring cultured cells (such as fluorescence
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FIG. 4. Reversal potential of VV:H4-induced currents in an
RBL-1 cell. A 4-ms step from a holding potential of -100 mV to an
activation potential of +20 mV was followed by a return to a family
of test potentials from -100 to -20 mV. The tail currents (Inset)
elicited by this protocol were fit with single exponentials. The
amplitude of the zero-time intercept of the exponential fits is plotted
against the test potential. The currents reversed at -78 mV. Leakage
currents were removed by subtraction of current traces elicited by
pulses from a holding potential of -30 mV. No transient outward
current was activated by the latter protocol.
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FIG. 5. Pharmacological block of VV:H4-induced transient out-
ward currents in an RBL-1 cell. (A) Currents recorded during a
voltage step from -100mV to 0mV before (top trace), during (middle
trace), and after (bottom trace) exposure to 10 mM 4-aminopyridine
pressure-ejected from a nearby pipet. (B) Currents recorded before
(upper trace) and during (lower trace) bath exposure to 10 nM
charybdotoxin. The charybdotoxin block was only partly reversible,
even after a 10-min wash.
microscopy), the virus may provide an alternative to con-
struction of a stably transfected cell line.
A principal advantage of vaccinia over other transient
expression systems is the broad range of mammalian cell
types that can be infected, including primary cells (G.T.,
unpublished work). Thus, VV may prove useful for expres-
sion of polypeptides requiring cell-specific posttranslational
processing or when additional, cell-specific subunits are
required for complete functional reconstitution. Like the
oocyte, VV can be used to coexpress multiple foreign gene
products in a single cell (5, 17-19) and may prove useful in
attempts to study intracellular signal pathways. The large
fraction of expressing cells is also a considerable advantage
as compared to the usual transient transfection techniques.
The four cell types chosen for this study are from different
origins; only the PC-12 cells are derived from excitable
tissue. Transient potassium currents are not usually seen in
any of the cell types, except as rare (<2% of cells) constit-
uents in PC-12 cells (20). We observed no striking differences
in the kinetics of the VV:H4-induced currents among the four
cell types; all appeared similar to those seen following
injection of H4 transcript into Xenopus oocytes (6). It is
possible, however, that single channel recording from VV-
infected cells may yet reveal differences in kinetics or con-
ductance that are not apparent in the macroscopic currents.
Aside from the sensitivity to charybdotoxin, the properties of
the Shaker H4 channels strongly resemble those of transient
potassium channels observed in fly muscle (7). Our obser-
vation that charybdotoxin blocks A-type currents expressed
in cultured mammalian cells infected with VV:H4 demon-
strates that charybdotoxin sensitivity is not an artifact of
expression in Xenopus oocytes, but it does not explain the
lack of charybdotoxin blockade of A-current channels in
Drosophila (15, 16). One possibility is a difference in post-
translational processing between Drosophila and vertebrate
cells.
We are encouraged that the virus-induced expression of
A-type currents in PC-12 cells did not alter the properties of
the endogenous voltage-gated currents. This result supports
the general feasibility of studying more complex interactions
between native membrane constituents and those expressed
heterologously by VV infection.
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